Literature DB >> 19925564

Snail and Cox-2 expressions are associated with WHO tumor grade and survival rate of patients with gliomas.

Jaekyung Myung1, Byung-Kyu Cho, Young-Soon Kim, Sung-Hye Park.   

Abstract

The transcriptional factor Snail and enzyme cyclo-oxygenase-2 (Cox-2) are suggested to be important effectors of invasiveness and tumorigenesis in various tumors. Tumors of higher grade have the propensity for tumor cell migration and invasiveness. This study was performed in order to evaluate the association between Snail and Cox-2 expressions and their values as prognostic factors in various grades of glioma, Specimens of 56 patients with glioma were used in the study. Univariate analysis showed that WHO tumor grade, and expressions of Snail and Cox-2 were significant prognostic factors affecting overall and disease progression-free survival rates. In the multivariate analysis by Cox regression model, only WHO tumor grade was shown to be a significant independent prognostic factor of overall and progression-free survival rates. In conclusion, Snail and Cox-2 expressions were associated with WHO grade in gliomas and may be used as prognostic indicators.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19925564     DOI: 10.1111/j.1440-1789.2009.01072.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  16 in total

1.  SNAI1 is involved in the proliferation and migration of glioblastoma cells.

Authors:  Sung-Pil Han; Ji-Hoon Kim; Myoung-Eun Han; Hey-Eun Sim; Ki-Sun Kim; Sik Yoon; Sun-Yong Baek; Bong-Seon Kim; Sae-Ock Oh
Journal:  Cell Mol Neurobiol       Date:  2011-01-12       Impact factor: 5.046

2.  HGF/MET signaling promotes glioma growth via up-regulation of Cox-2 expression and PGE2 production.

Authors:  Yan Zhao; Ying Sun; Haiyan Zhang; Xing Liu; Wenzong Du; Yongli Li; Junhe Zhang; Lingchao Chen; Chuanlu Jiang
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

Review 3.  Interleukins in glioblastoma pathophysiology: implications for therapy.

Authors:  Y T Yeung; K L McDonald; T Grewal; L Munoz
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

4.  STAT3 silencing inhibits glioma single cell infiltration and tumor growth.

Authors:  Maike Priester; Ekaterini Copanaki; Vida Vafaizadeh; Sandra Hensel; Christian Bernreuther; Markus Glatzel; Volker Seifert; Bernd Groner; Donat Kögel; Jakob Weissenberger
Journal:  Neuro Oncol       Date:  2013-03-13       Impact factor: 12.300

5.  Snail plays an oncogenic role in glioblastoma by promoting epithelial mesenchymal transition.

Authors:  Jae Kyung Myung; Seung Ah Choi; Seung-Ki Kim; Kyu-Chang Wang; Sung-Hye Park
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

6.  Aligned chitosan-polycaprolactone polyblend nanofibers promote the migration of glioblastoma cells.

Authors:  Forrest M Kievit; Ashleigh Cooper; Soumen Jana; Matthew C Leung; Kui Wang; Dennis Edmondson; David Wood; Jerry S H Lee; Richard G Ellenbogen; Miqin Zhang
Journal:  Adv Healthc Mater       Date:  2013-06-17       Impact factor: 9.933

7.  Dehydrocostus lactone, a natural sesquiterpene lactone, suppresses the biological characteristics of glioma, through inhibition of the NF-κB/COX-2 signaling pathway by targeting IKKβ.

Authors:  Jinkui Wang; Zhenlong Yu; Chao Wang; Xiangge Tian; Xiaokui Huo; Yan Wang; Chengpeng Sun; Lei Feng; Jing Ma; Baojing Zhang; Qining Yang; Xiaochi Ma; Yinghui Xu
Journal:  Am J Cancer Res       Date:  2017-06-01       Impact factor: 6.166

8.  Pantoprazole Induces Mitochondrial Apoptosis and Attenuates NF-κB Signaling in Glioma Cells.

Authors:  Khamushavalli Geeviman; Deepak Babu; Phanithi Prakash Babu
Journal:  Cell Mol Neurobiol       Date:  2018-10-09       Impact factor: 5.046

9.  Global profiling of metabolic adaptation to hypoxic stress in human glioblastoma cells.

Authors:  Paulina Kucharzewska; Helena C Christianson; Mattias Belting
Journal:  PLoS One       Date:  2015-01-29       Impact factor: 3.240

10.  Snail depletes the tumorigenic potential of glioblastoma.

Authors:  K Savary; D Caglayan; L Caja; K Tzavlaki; S Bin Nayeem; T Bergström; Y Jiang; L Uhrbom; K Forsberg-Nilsson; B Westermark; C-H Heldin; M Ferletta; A Moustakas
Journal:  Oncogene       Date:  2013-03-25       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.